Ocuphire Pharma (NASDAQ:OCUP) just reported results for the fourth quarter of 2023.
- Ocuphire Pharma reported earnings per share of -21 cents. This was below the analyst estimate for EPS of -5 cents.
- The company reported revenue of $1.69 million.
- This was 68.39% worse than the analyst estimate for revenue of $5.35 million.